» Articles » PMID: 19492422

A Novel Osteoclast Precursor Cell Line, 4B12, Recapitulates the Features of Primary Osteoclast Differentiation and Function: Enhanced Transfection Efficiency Before and After Differentiation

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2009 Jun 4
PMID 19492422
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoclasts are bone-resorbing multinucleated cells differentiated from monocyte/macrophage lineage precursors. A novel osteoclast precursor cell line, 4B12 was established from Mac-1(+)c-Fms(+)RANK(+) cells from calvaria of 14-day-old mouse embryos using immunofluorescence and cell-sorting methods. Like M-CSF-dependent bone marrow macrophages (M-BMMs), M-CSF is required for 4B12 cells to differentiate into TRAP-positive multinucleated cells [TRAP(+) MNCs] in the presence of RANKL. Bone-resorbing osteoclasts differentiated from 4B12 cells on dentine slices possess both a clear zone and ruffled borders and express osteoclast-specific genes. Bone-resorbing activity, but not TRAP, was enhanced in the presence of IL-1alpha. The number of TRAP(+) MNCs and the number of pits formed from 4B12 cells on dentine slices was fourfold higher than that from M-BMMs. 4B12 cells were identified as macrophages with Mac-1 and F4/80, yet lost these markers upon differentiation into osteoclasts as determined by confocal laser scanning microscopy. The 4B12 cells do not have the potential to differentiate into dendritic cells indicating commitment to the osteoclast lineage. 4B12 cells are readily transfectable with siRNA transfection before and after differentiation. These data show that 4B12 cells faithfully replicate the properties of primary cells and are a useful and powerful model for analyzing the molecular and cellular regulatory mechanisms of osteoclastogenesis and osteoclast function.

Citing Articles

FeO Magnetic Nanoparticles Under Static Magnetic Field Improve Osteogenesis via RUNX-2 and Inhibit Osteoclastogenesis by the Induction of Apoptosis.

Marycz K, Sobierajska P, Wiglusz R, Idczak R, Nedelec J, Fal A Int J Nanomedicine. 2022; 15:10127-10148.

PMID: 36213447 PMC: 9537728. DOI: 10.2147/IJN.S256542.


Impact of Polyrhodanine Manganese Ferrite Binary Nanohybrids (PRHD@MnFeO) on Osteoblasts and Osteoclasts Activities-A Key Factor in Osteoporosis Treatment.

Marycz K, Kowalczuk A, Turlej E, Zachanowicz E, Tomaszewska A, Kulpa-Greszta M Materials (Basel). 2022; 15(11).

PMID: 35683288 PMC: 9181943. DOI: 10.3390/ma15113990.


Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of....

Marycz K, Smieszek A, Kornicka-Garbowska K, Pielok A, Janeczek M, Lipinska A Int J Nanomedicine. 2021; 16:6049-6065.

PMID: 34511905 PMC: 8418301. DOI: 10.2147/IJN.S316240.


CoMnFeO@PMMA Nanoparticles Promotes Preosteoblast Differentiation through Activation of Axis and Modulates Osteoclastogenesis under Magnetic Field Conditions.

Marycz K, Turlej E, Kornicka-Garbowska K, Zachanowicz E, Tomaszewska A, Kulpa-Greszta M Materials (Basel). 2021; 14(17).

PMID: 34501099 PMC: 8434396. DOI: 10.3390/ma14175010.


Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast - A Novel Concept for Osteoporosis....

Marycz K, Smieszek A, Marcinkowska K, Sikora M, Turlej E, Sobierajska P Int J Nanomedicine. 2021; 16:3429-3456.

PMID: 34040372 PMC: 8140937. DOI: 10.2147/IJN.S303412.


References
1.
Hentunen T, Jackson S, Chung H, Reddy S, Lorenzo J, Choi S . Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-X(L) and simian virus 40 large T antigen. Endocrinology. 1999; 140(7):2954-61. DOI: 10.1210/endo.140.7.6867. View

2.
Kraal G, Rep M, Janse M . Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An immunohistochemical study. Scand J Immunol. 1987; 26(6):653-61. DOI: 10.1111/j.1365-3083.1987.tb02301.x. View

3.
Mbalaviele G, Jaiswal N, Meng A, Cheng L, van den Bos C, Thiede M . Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology. 1999; 140(8):3736-43. DOI: 10.1210/endo.140.8.6880. View

4.
Walsh C, Beresford J, Birch M, Boothroyd B, Gallagher J . Application of reflected light microscopy to identify and quantitate resorption by isolated osteoclasts. J Bone Miner Res. 1991; 6(7):661-71. DOI: 10.1002/jbmr.5650060703. View

5.
Chambers T, Owens J, Hattersley G, Jat P, Noble M . Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci U S A. 1993; 90(12):5578-82. PMC: 46764. DOI: 10.1073/pnas.90.12.5578. View